UBS AM’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-38,898
| Closed | -$79K | – | 2662 |
|
|
2016
Q1 | $79K | Sell |
38,898
-2,100
| -5% | -$3.75K | ﹤0.01% | 2589 |
|
|
2015
Q4 | $102K | Hold |
40,998
| – | – | ﹤0.01% | 2653 |
|
|
2015
Q3 | $107K | Hold |
40,998
| – | – | ﹤0.01% | 2608 |
|
|
2015
Q2 | $128K | Hold |
40,998
| – | – | ﹤0.01% | 2652 |
|
|
2015
Q1 | $117K | Hold |
40,998
| – | – | ﹤0.01% | 2572 |
|
|
2014
Q4 | $106K | Sell |
40,998
-474,400
| -92% | -$2.08M | ﹤0.01% | 2568 |
|
|
2014
Q3 | $3.85M | Sell |
515,398
-39,249
| -7% | -$367K | ﹤0.01% | 1092 |
|
|
2014
Q2 | $6.53M | Sell |
554,647
-26,827
| -5% | -$286K | 0.01% | 971 |
|
|
2014
Q1 | $6.75M | Sell |
581,474
-80,713
| -12% | -$950K | 0.01% | 961 |
|
|
2013
Q4 | $7.21M | Sell |
662,187
-40,837
| -6% | -$402K | 0.01% | 919 |
|
|
2013
Q3 | $7.57M | Buy |
703,024
+267,843
| +62% | +$3.05M | 0.01% | 876 |
|
|
2013
Q2 | $5.1M | Buy |
+435,181
| New | +$4.35M | 0.01% | 947 |
|
UBS AM's SZYM Position: Q2 2016 in Review
UBS AM sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 38,898 shares — an estimated $79K sold.
UBS AM first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $7.57M in Q3 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- UBS AM reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- UBS AM sold 38,898 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $79K.
- UBS AM first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- UBS AM's SOLAZYME INC COM STK (DE) position peaked at $7.57M in Q3 2013.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.